Tarpana and Anjana kriya in Myopia

A CLINICAL STUDY ON COMPARISON BETWEEN AKSHI-TARPANA AND ANJANA IN THE MANAGEMENT OF TIMIRA W.S.R TO MYOPIA

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/01/006539

Enrollment

Registered

2016-01-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- refractive errors

Interventions

Intervention1: Group a: Tarpana with Triphladi ghrita Oral compound(Anubhuta yoga) will be same Control Intervention1: Group b: Anjana with Vimaladi varti Oral compound(Anubhuta yoga) will be sam

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Timira - Myopia upto -6D within the age group of 7-30 years with normal fundus

Exclusion criteria

Exclusion criteria: Patient having any other known ocular pathology eg. cataract, corneal opacity, H/O iridocyclitis, Glaucoma ,other Retinal diseases etc. Patient below age of 7 years and above 30 years. Patient having myopia above -6D. Patient having myopic degenerative changes. Patient having Juvenile Diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
Changes in diopteric power of spectaclesTimepoint: two months	—

Secondary

Measure	Time frame
Relief in sign and symptoms of myopiaTimepoint: two months	—

Countries

India

Contacts

Public ContactDr Majusha Rajgopala

IPGT AND RA, G.A.U. JAMNAGAR

bhatrajma2008@gmail.com9428400759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026